α-emitters

You have access
Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer
Mohamed El Fakiri, Nawal Ayada, Marius Müller, Lars Hvass, Teodor H. Gamzov, Anne Skovsbo Clausen, Nicolas M. Geis, Nils Steinacker, Ellinor Hansson, Sture Lindegren, Emma Aneheim, Holger Jensen, Ann-Christin Eder, Andreas I. Jensen, Christian B.M. Poulie, Andreas Kjaer, Matthias Eder and Matthias M. Herth

Journal of Nuclear Medicine April 1, 2024, 65 (4) 593-599; DOI: https://doi.org/10.2967/jnumed.123.267043
You have access
Cyclotron-Produced ¹³²La as a PET Imaging Surrogate for Therapeutic ²²⁵Ac
Eduardo Aluicio-Sarduy, Todd E. Barnhart, Jamey Weichert, Reinier Hernandez and Jonathan W. Engle

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1012-1015; DOI: https://doi.org/10.2967/jnumed.120.255794
You have access
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2
Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1020-1027; DOI: https://doi.org/10.2967/jnumed.117.204651
You have access
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
Sophie Poty, Lynn C. Francesconi, Michael R. McDevitt, Michael J. Morris and Jason S. Lewis

Journal of Nuclear Medicine June 1, 2018, 59 (6) 878-884; DOI: https://doi.org/10.2967/jnumed.116.186338

Main menu